Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (1) Bähring, Sylvia Dr. (1) Bartolomaeus, Theda (1) Borodina, Tatiana Dr. (1) Bunse, Mario Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Del Giudice, Simone (1) Diecke, Sebastian Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Forslund, Sofia Dr. (1) Gotthardt, Michael Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (1) Izsvak, Zsuzsanna Dr. (1) Keller, Ulrich Dr. med. (2) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Klußmann, Enno PD Dr. (1) Landthaler, Markus Prof. Dr. (3) Langanki, Reika (1) Leutz, Achim Prof. Dr. (1) Liu, Tiannan (1) Marko, Lajos Dr. (1) Mastrobuoni, Guido Dr. (1) Mathas, Stephan Dr. (22) Mertins, Philipp Dr. (1) Minia, Igor Dr. (1) Müller, Dominik Prof. Dr. (1) Na, Il-Kang Dr. (1) Napieczynska, Hanna Dr. (1) Nazare, Marc (1) Ohler, Uwe Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Popova, Elena Dr. (1) Prigione, Alessandro Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (25) Sholokh, Anastasiia (1) Simon, Katja Prof. Dr. (1) Singh, Manvendra Dr. (1) Sporbert, Anje Dr. (1) Spuler, Simone Prof. (1) Sunaga-Franze, Daniele Yumi Dr. (1) Taube, Martin (1) Villamil, Gabriel (1) Wyler, Emanuel Dr. (1) Zühlke, Kerstin Dr. (1) (-) Janz, Martin Dr. (17) (-) Lusatis, Simone (1) (-) Wollert-Wulf, Brigitte (2) (-) Ziehm, Matthias Dr. (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) (-) 2004 (2) (-) 2005 (2) (-) 2006 (4) (-) 2007 (2) (-) 2008 (2) 2009 (3) (-) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2017 (3) 2018 (1) 2020 (4) 2021 (6) (-) 2022 (5) 2023 (6) 2024 (1) AG Müller/Dechend (ECRC) (1) (-) Biology of Malignant Lymphomas (17) Biomedical Image Analysis (1) Cancer Genetics and Cellular Stress Responses (1) Flow Cytometry (1) Genetics and Genomics of Cardiovascular Diseases (1) Genetics of Congenital Heart Disease (1) Genomics (2) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Dysregulations in Oncology (1) Mechanism-based Cancer Therapies (3) Microenvironmental Regulation in Autoimmunity and Cancer (2) Mobile DNA (1) Molecular Immunology and Gene Therapy (2) (-) Proteome Dynamics (1) Proteomics (3) RNA Biology and Posttranscriptional Regulation (3) Translational Bioinformatics (20) Translational Tumorimmunology (1) 18 Results: Active Filter: Janz, Martin Dr.Lusatis, SimoneWollert-Wulf, BrigitteZiehm, Matthias Dr.Biology of Malignant LymphomasProteome Dynamics2004200520062007200820102022 Sort: Result score Newest to oldest Oldest to newest April 01, 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas September 01, 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken Pagination Current page 1 Page 2 Next page Next › Last page Last »
April 01, 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
October 15, 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas
September 01, 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas
May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken